107 related articles for article (PubMed ID: 37271592)
21. Development and validation of a model to predict outcomes of colon cancer surveillance.
Rose J; Homa L; Kong CY; Cooper GS; Kattan MW; Ermlich BO; Meyers JP; Primrose JN; Pugh SA; Shinkins B; Kim U; Meropol NJ
Cancer Causes Control; 2019 Jul; 30(7):767-778. PubMed ID: 31129907
[TBL] [Abstract][Full Text] [Related]
22. Oncologic outcomes of pathologic T4 and T3 colon cancer patients diagnosed with clinical T4 stage disease using preoperative computed tomography scan.
Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
Surg Oncol; 2022 May; 41():101749. PubMed ID: 35358915
[TBL] [Abstract][Full Text] [Related]
23. Extent of enhancement on multiphase contrast-enhanced CT images is a potential prognostic factor of stage I-III colon cancer.
Wang Z; Ye Y; Hu Y; Han S; Sun L; Xu D; Ding K
Eur Radiol; 2019 Mar; 29(3):1114-1123. PubMed ID: 30255251
[TBL] [Abstract][Full Text] [Related]
24. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
[TBL] [Abstract][Full Text] [Related]
25. Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings.
Tashiro J; Yamaguchi S; Ishii T; Suzuki A; Kondo H; Morita Y; Hara K; Koyama I
World J Surg Oncol; 2014 May; 12():145. PubMed ID: 24884880
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
27. Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.
Wang L; Hirano Y; Ishii T; Kondo H; Hara K; Obara N; Yamaguchi S
World J Surg Oncol; 2020 Mar; 18(1):54. PubMed ID: 32160919
[TBL] [Abstract][Full Text] [Related]
28. Current treatment and surveillance modalities are not sufficient for advanced stage III colon cancer: Result from a multicenter cohort analysis.
Li J; Xie Y; Huang Z; Shen D; Zhuang Z; Zhu M; Huang Y; He R; Wang X; Huang M; Luo Y; Yu H
Cancer Med; 2021 Dec; 10(24):8924-8933. PubMed ID: 34786881
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
30. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
[TBL] [Abstract][Full Text] [Related]
31. Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project.
Souglakos J; Boukovinas I; Kakolyris S; Xynogalos S; Ziras N; Athanasiadis A; Androulakis N; Christopoulou A; Vaslamatzis M; Ardavanis A; Emmanouilides C; Bompolaki I; Kourousis C; Makrantonakis P; Christofyllakis C; Athanasiadis E; Kentepozidis N; Karampeazis A; Katopodi U; Anagnosopoulos A; Papadopoulos G; Prinarakis E; Kalisperi A; Mavroudis D; Georgoulias V
Ann Oncol; 2019 Aug; 30(8):1304-1310. PubMed ID: 31228203
[TBL] [Abstract][Full Text] [Related]
32. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
34. Use of Imaging During Staging and Surveillance of Localized Colon Cancer in a Large Insured Population.
Durani U; Asante D; Halfdanarson T; Heien HC; Sangaralingham L; Thompson CA; Peethambaram P; Quevedo FJ; Go RS
J Natl Compr Canc Netw; 2019 Nov; 17(11):1355-1361. PubMed ID: 31693982
[TBL] [Abstract][Full Text] [Related]
35. Characteristics Associated With Nonreceipt of Surveillance Testing and the Relationship With Survival in Stage II and III Colon Cancer.
Hines RB; Jiban MJH; Lee E; Odahowski CL; Wallace AS; Adams SJE; Rahman SMM; Zhang S
Am J Epidemiol; 2021 Feb; 190(2):239-250. PubMed ID: 32902633
[TBL] [Abstract][Full Text] [Related]
36. Postoperative computed tomography scan surveillance for patients with stage II and III colorectal cancer: worthy of further study?
Mortazavi A; Shaukat A; Othman E; Kepner JL; Fakih MG; Kuvshinoff BW; Smith JL; Javle MM
Am J Clin Oncol; 2005 Feb; 28(1):30-5. PubMed ID: 15685032
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
38. Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre.
Tan E; Lam S; Han SP; Storey D; Sandroussi C
Langenbecks Arch Surg; 2021 Jun; 406(4):1057-1069. PubMed ID: 33770264
[TBL] [Abstract][Full Text] [Related]
39. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant Chemotherapy for Locally Advanced T4 Colon Cancer: A Nationwide Propensity-Score Matched Cohort Analysis.
de Gooyer JM; Verstegen MG; 't Lam-Boer J; Radema SA; Verhoeven RHA; Verhoef C; Schreinemakers JMJ; de Wilt JHW
Dig Surg; 2020; 37(4):292-301. PubMed ID: 31661689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
